Identification of Biowaivers Among Class II Drugs: Theoretical Justification and Practical Examples

Author： Rinaki Eleni Dokoumetzidis Aristides Valsami Georgia Macheras Panos

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.21, Iss.9, 2004-09, pp. : 1567-1572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Antihypertensive Drugs on Central Blood Pressure Beyond Peripheral Blood Pressure. Part II: Evidence for Specific Class-Effects of Antihypertensive Drugs on Pressure Amplification

Current Pharmaceutical Design, Vol. 15, Iss. 3, 2009-01 ,pp. : 272-289

Bentham Science Publishers

Access to resources Recommend Favorite

Current issues in biowaivers and biosimilars

By Endrenyi Laszlo

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 139-142

Informa Healthcare

Access to resources Recommend Favorite

Postprandial Changes in Solubilizing Capacity of Human Intestinal Fluids for BCS Class II Drugs

By Clarysse Sarah Psachoulias Dimitrios Brouwers Joachim Tack Jan Annaert Pieter Duchateau Guus Reppas Christos Augustijns Patrick

Pharmaceutical Research, Vol. 26, Iss. 6, 2009-06 ,pp. : 1456-1466

Springer Publishing Company

Access to resources Recommend Favorite

Potential use of phospholipids in combination with hydrophilic carriers for enhancement of the dissolution and oral bioavailability of imidazole antifungal Class II drugs

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 11, 2015-11 ,pp. : 706-715

Govi-Verlag

Access to resources Recommend Favorite

Insight into the Development of Dissolution Media for BCS Class II Drugs: A Review from Quality Control and Prediction of In Vivo Performance Perspectives

Current Drug Delivery, Vol. 13, Iss. 7, 2016-10 ,pp. : 1004-1020

Bentham Science Publishers

Access to resources Recommend Favorite